Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy

Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy

A 49‐year‐old patient with pulmonary hypertrophic osteoarthropathy was treated with 0.4 mg of atropine sulfate every 4 hours for 14 days. A good clinical response was obtained as measured by handgrip strength, range of motion, and quantitative thermography. Chemical vagotomy supports the hypothesis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis and rheumatism 1980-07, Vol.23 (7), p.822-824
Hauptverfasser: Lopez‐Enriquez, Edrick, Morales, A. Raphael, Robert, Francisco
Format: Artikel
Sprache:eng
Schlagworte:
Atropine - therapeutic use
Humans
Male
Middle Aged
Osteoarthropathy, Secondary Hypertrophic - drug therapy
Physical Exertion
Thermography
Vagotomy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 824
container_issue 7
container_start_page 822
container_title Arthritis and rheumatism
container_volume 23
creator Lopez‐Enriquez, Edrick
Morales, A. Raphael
Robert, Francisco
description A 49‐year‐old patient with pulmonary hypertrophic osteoarthropathy was treated with 0.4 mg of atropine sulfate every 4 hours for 14 days. A good clinical response was obtained as measured by handgrip strength, range of motion, and quantitative thermography. Chemical vagotomy supports the hypothesis of the vagal reflex as the pathophysiological mechanism in pulmonary hypertrophic osteoarthropathy.
doi_str_mv 10.1002/art.1780230708
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75225713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75225713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4068-ad46a01b54e3de328a87a0fc8a8b9565fbb53a6c1b61d2fcef7bc2f4ba5f90923</originalsourceid><addsrcrecordid>eNqFUE1LxDAUDKKs6-rVm9CTt675aPpxXJb1AxYEWc8hSV9opW1q0iL992bZot48DcObN_PeIHRL8JpgTB-kG9YkyzFlOMP5GVoSTosYE0bO0RJjnMSMF-QSXXn_EShlnC3QIktwWjC2RLudMaCHyJpIDs72dQeRHxsjB4jqLurHprWddFNUTT24o6KqdWT9ADYkV4HLoZqu0YWRjYebGVfo_XF32D7H-9enl-1mH-uQl8eyTFKJieIJsBIYzWWeSWx0QFXwlBulOJOpJiolJTUaTKY0NYmS3BS4oGyF7k--vbOfI_hBtLXX0DSyAzt6kXFKeUZYEK5PQu2s9w6M6F3dhj8EweLYmwjXi9_ewsLd7DyqFsof-VxUmBen-VfdwPSPm9i8Hf54fwNUmntR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75225713</pqid></control><display><type>article</type><title>Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Lopez‐Enriquez, Edrick ; Morales, A. Raphael ; Robert, Francisco</creator><creatorcontrib>Lopez‐Enriquez, Edrick ; Morales, A. Raphael ; Robert, Francisco</creatorcontrib><description>A 49‐year‐old patient with pulmonary hypertrophic osteoarthropathy was treated with 0.4 mg of atropine sulfate every 4 hours for 14 days. A good clinical response was obtained as measured by handgrip strength, range of motion, and quantitative thermography. Chemical vagotomy supports the hypothesis of the vagal reflex as the pathophysiological mechanism in pulmonary hypertrophic osteoarthropathy.</description><identifier>ISSN: 0004-3591</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/art.1780230708</identifier><identifier>PMID: 7406933</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Atropine - therapeutic use ; Humans ; Male ; Middle Aged ; Osteoarthropathy, Secondary Hypertrophic - drug therapy ; Physical Exertion ; Thermography ; Vagotomy</subject><ispartof>Arthritis and rheumatism, 1980-07, Vol.23 (7), p.822-824</ispartof><rights>Copyright © 1980 American College of Rheumatology</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4068-ad46a01b54e3de328a87a0fc8a8b9565fbb53a6c1b61d2fcef7bc2f4ba5f90923</citedby><cites>FETCH-LOGICAL-c4068-ad46a01b54e3de328a87a0fc8a8b9565fbb53a6c1b61d2fcef7bc2f4ba5f90923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.1780230708$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.1780230708$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7406933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lopez‐Enriquez, Edrick</creatorcontrib><creatorcontrib>Morales, A. Raphael</creatorcontrib><creatorcontrib>Robert, Francisco</creatorcontrib><title>Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>A 49‐year‐old patient with pulmonary hypertrophic osteoarthropathy was treated with 0.4 mg of atropine sulfate every 4 hours for 14 days. A good clinical response was obtained as measured by handgrip strength, range of motion, and quantitative thermography. Chemical vagotomy supports the hypothesis of the vagal reflex as the pathophysiological mechanism in pulmonary hypertrophic osteoarthropathy.</description><subject>Atropine - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Osteoarthropathy, Secondary Hypertrophic - drug therapy</subject><subject>Physical Exertion</subject><subject>Thermography</subject><subject>Vagotomy</subject><issn>0004-3591</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUE1LxDAUDKKs6-rVm9CTt675aPpxXJb1AxYEWc8hSV9opW1q0iL992bZot48DcObN_PeIHRL8JpgTB-kG9YkyzFlOMP5GVoSTosYE0bO0RJjnMSMF-QSXXn_EShlnC3QIktwWjC2RLudMaCHyJpIDs72dQeRHxsjB4jqLurHprWddFNUTT24o6KqdWT9ADYkV4HLoZqu0YWRjYebGVfo_XF32D7H-9enl-1mH-uQl8eyTFKJieIJsBIYzWWeSWx0QFXwlBulOJOpJiolJTUaTKY0NYmS3BS4oGyF7k--vbOfI_hBtLXX0DSyAzt6kXFKeUZYEK5PQu2s9w6M6F3dhj8EweLYmwjXi9_ewsLd7DyqFsof-VxUmBen-VfdwPSPm9i8Hf54fwNUmntR</recordid><startdate>198007</startdate><enddate>198007</enddate><creator>Lopez‐Enriquez, Edrick</creator><creator>Morales, A. Raphael</creator><creator>Robert, Francisco</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198007</creationdate><title>Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy</title><author>Lopez‐Enriquez, Edrick ; Morales, A. Raphael ; Robert, Francisco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4068-ad46a01b54e3de328a87a0fc8a8b9565fbb53a6c1b61d2fcef7bc2f4ba5f90923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Atropine - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Osteoarthropathy, Secondary Hypertrophic - drug therapy</topic><topic>Physical Exertion</topic><topic>Thermography</topic><topic>Vagotomy</topic><toplevel>online_resources</toplevel><creatorcontrib>Lopez‐Enriquez, Edrick</creatorcontrib><creatorcontrib>Morales, A. Raphael</creatorcontrib><creatorcontrib>Robert, Francisco</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lopez‐Enriquez, Edrick</au><au>Morales, A. Raphael</au><au>Robert, Francisco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>1980-07</date><risdate>1980</risdate><volume>23</volume><issue>7</issue><spage>822</spage><epage>824</epage><pages>822-824</pages><issn>0004-3591</issn><eissn>1529-0131</eissn><abstract>A 49‐year‐old patient with pulmonary hypertrophic osteoarthropathy was treated with 0.4 mg of atropine sulfate every 4 hours for 14 days. A good clinical response was obtained as measured by handgrip strength, range of motion, and quantitative thermography. Chemical vagotomy supports the hypothesis of the vagal reflex as the pathophysiological mechanism in pulmonary hypertrophic osteoarthropathy.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>7406933</pmid><doi>10.1002/art.1780230708</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0004-3591
ispartof Arthritis and rheumatism, 1980-07, Vol.23 (7), p.822-824
issn 0004-3591
1529-0131
language eng
recordid cdi_proquest_miscellaneous_75225713
source Wiley Online Library - AutoHoldings Journals; MEDLINE; Alma/SFX Local Collection
subjects Atropine - therapeutic use
Humans
Male
Middle Aged
Osteoarthropathy, Secondary Hypertrophic - drug therapy
Physical Exertion
Thermography
Vagotomy
title Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A27%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20atropine%20sulfate%20in%20pulmonary%20hypertrophic%20osteoarthropathy&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=Lopez%E2%80%90Enriquez,%20Edrick&rft.date=1980-07&rft.volume=23&rft.issue=7&rft.spage=822&rft.epage=824&rft.pages=822-824&rft.issn=0004-3591&rft.eissn=1529-0131&rft_id=info:doi/10.1002/art.1780230708&rft_dat=%3Cproquest_cross%3E75225713%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75225713&rft_id=info:pmid/7406933&rfr_iscdi=true